A national standard for evaluating antimicrobial textiles, in effect for nearly two decades, is undergoing systematic revision. In June 2025, the revision task for 'Textiles - Evaluation of Antibacterial Performance - Part 2: Absorption Method' (Plan No. 20251603-T-608) was officially assigned, and a review meeting was held in Zhejiang. This marks a comprehensive technical upgrade of the core evaluation system covering underwear, socks, home textiles, sportswear, and medical textiles.
Accelerated Revision and Systematic Restructuring
The national standard series for antibacterial textile evaluation consists of three parts: GB/T 20944.1-2007 (Agar Diffusion Method), GB/T 20944.2-2007 (Absorption Method), and GB/T 20944.3-2008 (Shake Flask Method). The revision task for Part 3 (Shake Flask Method) was assigned in June 2024 (Plan No. 20241952-T-608), and the standard has now been revised and is in the approval stage, set to fully replace the old version. The review meeting for Part 2 marks the intensive implementation phase of the series revision.
From a timeline perspective, the two revision tasks were assigned one year apart, but the pace of progress has accelerated. Part 3 moved from task assignment to approval in about one and a half years, while Part 2's review meeting occurred less than six months after the task was assigned, reflecting the urgent need for standard updates. The drafting units include testing institutions, research institutes, brand companies, and new material enterprises, indicating that the revision will balance laboratory rigor with practical industrial application.
Two Decades of Technological Evolution Expose Old Standard Limitations
Antibacterial textiles have expanded from early use in underwear and socks to sportswear, medical textiles, and home soft furnishings, with functional claims evolving from simple bacteriostasis to composite and long-lasting effects. Meanwhile, new antibacterial materials such as nano-silver, chitosan, and photocatalysts have emerged, along with significant advancements in testing equipment and methods. When the old standards were formulated, many technical paths did not exist, making it difficult for their test strains, culture conditions, and result determination methods to accurately reflect the true antibacterial performance of new materials.
For buyers, the direct risk of outdated standards is the difficulty in effectively identifying 'concept hype' and 'exaggerated claims.' Antibacterial performance is invisible and intangible; if testing methods cannot distinguish genuine antibacterial effects from surface treatment, substandard products may flood the market, disrupting supply chains. For manufacturers, a lack of unified scientific standards can misdirect R&D, and some enterprises may compromise actual performance to pass tests, damaging brand reputation.
Significance of Revision: From Testing Methods to Market Trust Reconstruction
The revised standards will adopt test methods that better reflect actual use conditions, improving accuracy and repeatability. This means that 'antibacterial' claims will be based on more solid data, and companies cannot rely solely on outdated test reports. For downstream purchasers, the standard upgrade adds a quality screening layer, allowing procurement decisions to rely more on authoritative test data and reducing disputes caused by non-functional claims.
For exporters, the degree of alignment with international standards will affect overseas market access. China exports a significant volume of antibacterial textiles, and if domestic standards lag behind advanced international levels, enterprises may face additional testing costs and delays when responding to foreign clients' factory audits and product certifications. If the revision aligns test methods with ISO or AATCC standards, it will directly reduce compliance costs for exporters.
Industrial Transmission: Antibacterial Function Shifts from 'Selling Point' to 'Standard Feature'
The deeper impact of the standard revision is that it may change the positioning of antibacterial function in the textile value chain. Previously, antibacterial treatment was often a differentiated selling point promoted by brand owners. With a complete standard system, antibacterial performance is expected to become a basic quality indicator, especially in fields with high hygiene requirements such as medical, maternal and infant, and hotel linen, where antibacterial will become a basic procurement threshold. This will force upstream fabric manufacturers to increase investment in antibacterial technology R&D and promote the maturity of the supply chain for antibacterial finishing agents and antibacterial fibers.
For fabric factories, the standard revision means re-validating existing antibacterial product test reports. Products tested under old standards may not meet new requirements, necessitating adjustments in process formulas or finishing steps. This poses both cost pressure and an opportunity for technical upgrade—enterprises that adapt to new standards early will gain an edge in bidding and brand partnerships.